Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the "Company") (NYSE:DDD). Among other items, 3D Systems reported weak results for the quarter, which missed consensus estimates for sales, operating income, and earnings. 3D Systems also reported a 21% drop in Healthcare revenue, largely tied to a change in accounting in its Regenerative Medicine program. Among other items, 3D Systems reported revenue of $94.5 million, missing consensus estimates by $5 million and representing an 8% year-over-year decline. 3D Systems also withdrew its full-year outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty.